Is MDM2 p.Glu150= (c.450A>G) pathogenic?

MDM2 p.Glu150= (c.450A>G) is classified Likely benign in MDM2 (ClinVar, Single submitter, 1 submitter; last evaluated 2024-10-13). Rare (popmax 0.109%, sas); Associated with Accelerated tumor formation, susceptibility to.

What condition is associated with MDM2 p.Glu150= (c.450A>G)?

MDM2 p.Glu150= (c.450A>G) is associated with Accelerated tumor formation, susceptibility to (ClinVar).

How common is MDM2 p.Glu150= (c.450A>G) in the general population?

MDM2 p.Glu150= (c.450A>G) is rare (popmax 0.109%, sas) (gnomAD).

MDM2 p.Glu150=

c.450A>G · rs201591724 · VCV1108186

Likely benign Single submitter

Classification

Likely benign

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

gnomAD v4.1

Rare

rare (popmax 0.109%, sas)

Conditions

Accelerated tumor formation, susceptibility to

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 8.1	GERP 1.9, phastCons 1
Overall
CADD	10.18	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.109% South Asian · 99/90,906 alleles

Filtering AF 0.0915% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.085%

Overall 0.0132% 213/1,613,580 alleles · rare

Ancestry group	Frequency	1 in
South Asiangrpmax	0.109%	918
Middle Eastern	0.0168%	5,944
European (non-Finnish)	0.00907%	11,027
Remaining individualsnot grpmax-eligible	0.0048%	20,820
Finnishnot grpmax-eligible	0.00312%	32,017
African / African-American	0.00133%	75,040

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: MDM2
Protein: p.Glu150=
Coding: c.450A>G
MANE Select: NM_002392
dbSNP: rs201591724
Type: single nucleotide variant
Location: chr12:68824578 (GRCh38)
Gene constraint: LOEUF 0.325 · pLI 1.00 (gnomAD)
Structure: AlphaFold pLDDT 63.24 · 148 PDB
Residue 150: the 'disordered' region; the 'interaction with pyhin1 and necessary for interaction with rffl and rnf34' region

Full MDM2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Accelerated tumor formation, susceptibility to — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

MDM2 c.523+5A>G Uncertain significance ★★ same condition
MDM2 p.Arg332His Uncertain significance ★★ same condition
MDM2 p.Asn117Ser Uncertain significance ★★ ⚠ same condition
MDM2 p.Asn374Ser Uncertain significance ★★ ⚠ same condition
MDM2 p.Gln414Leu Uncertain significance ★★ ⚠ same condition
MDM2 p.Glu273Ala Uncertain significance ★★ ⚠ same condition
MDM2 p.Gly341Glu Uncertain significance ★★ ⚠ same condition
MDM2 p.Ser122Leu Uncertain significance ★★ ⚠ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mdm2-p-glu150 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown